The overall aim of the research proposed in this application is to identify the role of central and peripheral mammalian bombesin-like (BN-like) peptides in the control of food intake. Two mammalian BN-like peptides have been identified: gastrin releasing peptide (GRP) and neuromedin B (NMB). These peptides and their corresponding receptors are differentially distributed in the gastrointestinal tract and central and peripheral nervous systems. BN-like peptides inhibit food intake following peripheral or central administration and these inhibitions appear to be mimicking actions of the endogenous peptides since both GRP and NMB receptor antagonist administration increases food intake. The proposed experiments examine the specific hypotheses that: 1) the receptor subtype mediation of peripheral and central BN-like peptides, differs; 2) the mediation of the satiety actions of peripheral BN-like peptides depends upon activation of a peripheral afferent pathway that results in a caudal hindbrain release of GRP; and 3) the central pathways mediating the satiety actions of central and peripheral BN-like peptides differ. The experiments addressing these hypotheses will employ specific antagonists and antisense oligonucleotides, c-fos immunohistochemical mapping, peripheral and central lesions and microstructural behavioral analyses. Finally, the investigators propose experiments to identify interactions between mammalian BN-like peptides and other peptides with anorexigenic actions to better understand the overall contribution of BN-like peptides in the controls of food intake. Together, the results of these experiments will significantly enhance our understanding of the actions of brain/gut peptides in food intake and body weight regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046448-07
Application #
6176221
Study Section
Special Emphasis Panel (ZRG2-BPO (01))
Program Officer
May, Michael K
Project Start
1994-05-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
7
Fiscal Year
2000
Total Cost
$245,140
Indirect Cost
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ladenheim, Ellen E; Behles, Robert R; Bi, Sheng et al. (2009) Gastrin-releasing peptide messenger ribonucleic acid expression in the hypothalamic paraventricular nucleus is altered by melanocortin receptor stimulation and food deprivation. Endocrinology 150:672-8
Ladenheim, Ellen E; Hamilton, Nahketah L; Behles, Robert R et al. (2008) Factors contributing to obesity in bombesin receptor subtype-3-deficient mice. Endocrinology 149:971-8
Ladenheim, Ellen E; Knipp, Susan (2007) Capsaicin treatment differentially affects feeding suppression by bombesin-like peptides. Physiol Behav 91:36-41
Ladenheim, Ellen E; Emond, M; Moran, T H (2005) Leptin enhances feeding suppression and neural activation produced by systemically administered bombesin. Am J Physiol Regul Integr Comp Physiol 289:R473-R477
Hensler, J G; Ladenheim, E E; Lyons, W E (2003) Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice. J Neurochem 85:1139-47
Ladenheim, E E; Hampton, L L; Whitney, A C et al. (2002) Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice. J Endocrinol 174:273-81
Moran, T H; Ladenheim, E E; Schwartz, G J (2001) Within-meal gut feedback signaling. Int J Obes Relat Metab Disord 25 Suppl 5:S39-41
Emond, M; Schwartz, G J; Ladenheim, E E et al. (1999) Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol 276:R1545-9
Ladenheim, E E; Wohn, A; White, W O et al. (1999) Inhibition of gastric emptying by bombesin-like peptides is dependent upon cholecystokinin-A receptor activation. Regul Pept 84:101-6
Ladenheim, E E; Moore, K A; Salorio, C F et al. (1997) Characterization of bombesin binding sites in the rat stomach. Eur J Pharmacol 319:245-51

Showing the most recent 10 out of 16 publications